Trust in the pharma industry is up among consumers, but slipped for the biotech sector in an unusual flip of sentiment about ...

Sanofi is overhauling its US commercial operations for its vaccines and will cut an undisclosed number of jobs, the company ...

The Massachusetts-based biotech Lumicell won FDA approval on Thursday for its drug-device combination product used to help ...

Corner Therapeutics' $54 million Series A will be used to bring new immunotherapies for cancer and infectious diseases into ...

DNA testing company 23andMe's CEO Anne Wojcicki is looking to take the company private, according to a Wednesday securities ...

A new startup aims to challenge Novo Nordisk and Eli Lilly's duopoly atop today's market for obesity drugs. The startup ...

As it waits for its acquisition by AbbVie to finalize, Cerevel reported a Phase 3 win for one of its programs in Parkinson’s ...

Pathios Therapeutics drew in $25 million for the first close of a Series B raise that should help the UK biotech test its ...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Vedanta Biosciences will lay off 12 workers from its CMC team, and a ...

Read on for news about Benitec Biopharma, Korro Bio, Zura Bio, Ocular Therapeutix and SK biopharmaceuticals: Biohaven to seek $230M public offering: The company’s offering follows an update to its BHV ...

Sanofi's oncology pruning will lead to the evaporation of an estimated $3 billion in potential biobucks for partner IGM ...

GSK’s market-leading Shingrix vaccine proved effective against shingles more than 10 years post-administration, creating a ...